Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2021

Jan 19, 2022

SELL
$14.7 - $28.67 $1,029 - $2,006
-70 Reduced 13.06%
466 $7,000
Q3 2021

Nov 09, 2021

BUY
$24.31 - $33.6 $1,701 - $2,352
70 Added 15.02%
536 $15,000
Q1 2020

Apr 27, 2020

BUY
$7.64 - $27.5 $3,560 - $12,815
466 New
466 $6,000

Others Institutions Holding NVTA

About Invitae Corp


  • Ticker NVTA
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 235,266,000
  • Description
  • Invitae Corporation, a medical genetics company, integrates genetic information into mainstream medicine to improve healthcare of people in the United States, Canada, and internationally. The company offers genetic tests in various clinical areas, including hereditary cancer, cardiology, neurology, pediatrics, oncology, metabolic conditions, and...
More about NVTA
Track This Portfolio

Track Hudock, Inc. Portfolio

Follow Hudock, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Hudock, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Hudock, Inc. with notifications on news.